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Abstract
We purposed to evaluate the role of Th inducing POZ-Kruppel Factor (ThPOK), a transcriptional regulator of T cell fate, in
tumour-induced immune system plasticity in colorectal carcinogenesis. The amounts of CD4+, CD8+ and CD56+ and
ThPOK+ cells infiltrate in normal colorectal mucosa (NM), in dysplastic aberrant crypt foci (microadenomas, MA), the earliest
detectable lesions in colorectal carcinogenesis, and in colorectal carcinomas (CRC), were measured, and the colocalization of
ThPOK with the above-mentioned markers of immune cells was evaluated using confocal microscopy. Interestingly, ThPOK
showed a prominent increase since MA. A strong colocalization of ThPOK with CD4 both in NM and in MA was observed,
weaker in carcinomas. Surprisingly, there was a peak in the colocalization levels of ThPOK with CD8 in MA, which was
evident, although to a lesser extent, in carcinomas, too. In conclusion, according to the data of the present study, ThPOK
may be considered a central regulator of the earliest events in the immune system during colorectal cancer development,
decreasing the immune response against cancer cells.
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Introduction
Solid tumours are commonly infiltrated by several immune cells
[1–3]. In cancer, immune cells play conflicting roles with potential
capability either in eliminating or promoting malignancy. In
contrast to infiltration of cells responsible for chronic inflamma-
tion, the presence of high numbers of lymphocytes, especially T
cells, has been reported to be an indicator of good prognosis in
many types of cancer [4–7]. However, even if the abundance of
tumour-infiltrating T-cells has been associated with improved
clinical outcome, in some types of cancer, including the colorectal
ones, the influence of immune cells on the prognosis is still a matter
of debate. Although the exact mechanism remains uncertain, the
adaptive immune system may play an important role in
suppressing tumour progression [8]. Tumour-infiltrating T-cells
may be suggestive of the host immune response to the tumour and
represent attractive targets for immunotherapy [9].
Both CD4+ and CD8+ T cells are required for effective tumour
cell elimination. It is well recognized that cytotoxic T lymphocytes
(CD8+ T cells) are crucial components of antitumour immunity,
since activated CD8+ T cells can directly kill tumour cells by the
release of granules including lytic components such as perforin and
enzymatic proteases (like granzyme B, GZMB) [10–12]. In a recent
investigation it was reported that the degree of infiltration with
CD8+ T cells is inversely correlated to the tumour stage and the
early signs of metastasis [13].
CD4+ T lymphocytes play a central role in orchestrating both
onset and maintenance of the adaptive immune response. Some
studies have suggested that a high CD8+/CD4+ T-cell ratio as
well as a high frequency of activated CD8+ T cells in colon cancer
are associated with the presence of an activated anticancer
immune reaction [14]. Furthermore, tumour tissue selective
infiltration of CD4+ T helper cells in colorectal cancer has been
demonstrated [15]. Increased infiltration of CD4+ T cells in
tumours may also be due to a greatly enhanced number of Foxp3+
regulatory T cells, that would explain the insufficiency of the
immune system to adequately attack primary tumours [16].
However, the function and phenotype of tumour infiltrating CD4+
T cells in colorectal cancer has not been yet characterized.
Natural killer (NK) cells and Natural killer T cells (NKT) are
CD56+ innate lymphocytes which have different biological
functions including the ability to recognize and kill a variety of
tumour cells before the antigen sensitization or clonal expansion
[17–20]. Recent studies indicate that these cells are scarce in CRC
tissue since the early stages, compared to nonmalignant colonic
tissue, and that a decreased number of CD56+ cells in patients
with CRC is associated with an increased frequency of cancer
recurrence [21–24].
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It remains important, therefore, to better understand how
tumours can evade immune-mediated attack once established.
The strategies to escape anti-tumor immune responses include the
limited priming or differentiation of antitumour T cells and the
role of tumour microenvironment to prevent infiltration or
activation of effector phase functions.
The Zbtb7b gene (referred to as ThPOK, T helper-inducing
POZ–Kruppel-like factor) is a transcriptional regulator, which is
necessary and sufficient to induce the commitment of the helper
lineage rather than the cytotoxic one in the T-cell subsets. ThPOK
is necessary for mediating CD4+ commitment and preventing
CD8+ commitment. Important is the key function of Zbtb7b in
preventing the expression of cytotoxic differentiation markers like
perforin and CD103 granzyme B, and the transcription factors
RUNX3 and Eomes [25–27]. It has been reported that ThPOK
expression into CD8+ T cells, in which normally it is not
expressed, results in the loss of some CD8+ T cell characteristics
like the expression of CD8 receptor and cytotoxic effector genes,
and in the up-regulation of genes typically expressed in helper
differentiation, including enhanced IL-2 production, although not
of CD4 itself [28,29].
Given the crucial role of ThPOK in cell fate determination of
the helper lineage, we evaluated ThPOK expression and
quantification along colorectal cancer development since its early
steps, including dysplastic aberrant crypt foci, referred to as
microadenomas [30]. The results of the present study suggest that
ThPOK can play an important role in controlling adaptive
immunity against colorectal tumours, since the early phases of
neoplastic transformation.
Materials and Methods
Ethics Statement
All patients enrolled in this study, which underwent colonoscopy
or surgical resection for colorectal cancer at the University
Hospital of Modena, were asked to give an informed written
consent to this study protocol, which was specifically approved by
the Comitato Etico Provinciale di Modena.
Study Population
Sixty samples of normal colorectal mucosa (NM) were collected
from 20 patients during colonoscopy, 3 samples for each patient.
One sample for each patient was fixed in formalin and embedded
in paraffin for histology and RNA extraction; the others were
frozen at 280uC. All patients had normal colonoscopy. Thirty
microadenomas (MA) were also identified in 11 patients, and
removed after operation for colorectal cancer on surgical speci-
mens, after staining of the mucosa with a 0.1% methylene-blue
solution in saline, and observation under a dissecting microscope
[30]. The average multiplicity of the MA examined is 79 (range
30–120), and all showed low grade dysplasia. One MA for each
patient was fixed in formalin and embedded in paraffin, the others
were frozen at 280uC. Finally, 60 samples of colorectal cancer
(CRC) were collected from 20 patients operated on for colon or
rectal cancer, a sample for each patient was fixed in formalin and
the other two were frozen at 280uC, as described above.
Western Blot Analysis
One sample frozen at 280uC for each subject was used for
western blot analysis. Whole cell lysates were obtained from 20
samples of NM, 10 MA, and 20 CRC, extracted with hypotonic
buffer (50 mM Tris-Cl, pH 7.8, containing 1% Nonidet P40,
140 mM NaCl, 0.1% SDS, 0.1% Na deoxycholate, 1 mM
Na3VO4, and freshly added protease inhibitor cocktail). Lysates
were then cleared by centrifugation for 15 min in a refrigerated
centrifuge, max speed, and immediately boiled in SDS sample
buffer. Forty mg of protein extract from each sample (NM, MA,
and CRC) were electrophoresed on SDS-PAGE and transferred to
nitrocellulose membranes. The membranes wereblocked with 3%
dry milk and 2% BSA in PBS-T and was incubated with the
following antibodies, diluted 1:1000 overnight at 4uC under
agitation: rabbit anti-zbtb7b (Sigma), mouse anti-CD4, mouse
anti-CD8, mouse anti-CD56 (Dako). After washing, the mem-
branes were incubated with secondary HPR-conjugated goat anti-
rabbit IgG antibody or goat anti-mouse IgG antibody (1:10000)
for 30 min at room temperature. Immunoreactive proteins were
detected with ECL (Amersham). Anti-mouse-a-actin (Sigma) was
used as loading control. Densitometry analysis was performed
using a KODAK (Rochester, NY) Image Station 440 cf system,
and semiquantitative analysis was performed with NIH Image J
software. For each sample and for each marker, the band
intensities were normalized to a-actin and results are expressed
as the normalized treatment to control ratio.
Evaluation of Immunofluorescence by Confocal
Microscopy
One sample frozen at 280uC for each subject was used for
immunofluorescence analysis to evaluate the expression of
ThPOK, CD4, CD8, CD-56, GZMB, RUNX3, and Foxp3,
proteins. Twenty samples of NM, 10 MA, and 20 CRC were fixed
in 4% paraformaldehyde in PBS, cryoprotected in 15% sucrose in
PBS, and frozen in iso-pentane cooled in liquid nitrogen.
Horizontal cryosections of the samples were cut (10 mm thick),
and haematoxylin and eosin staining was performed on sections to
control tissue integrity and histology. After a treatment with 3%
BSA in PBS for 30 min at room temperature, the cryostatic
sections were incubated with the primary antibodies (rabbit anti-
zbtb7b (Sigma), mouse anti-CD4, mouse anti-CD8, mouse anti-
CD56 (Dako), goat anti-Foxp3, goat anti-RUNX3 or anti
granzyme B (anti-GZMB) (Santa Cruz); diluted 1:25 in PBS
containing 3% BSA for 1 h at room temperature. After washing in
PBS, the samples were incubated for 1 h at room temperature
with the secondary antibodies diluted 1:20 in PBS containing 3%
BSA (sheep anti-mouse FITC conjugated, goat anti-rabbit TRITC
conjugated; sheep anti-goat CFTM64 conjugated (SIGMA)). After
washing in PBS and in H2O, the samples were counterstained with
1mg/ml DAPI in H2O and then mounted with anti-fading
medium (0.21 M DABCO and 90% glycerol in 0.02 M Tris,
pH 8.0). Negative control samples were not incubated with the
primary antibody. The confocal imaging was performed on a Leica
TCS SP2 AOBS confocal laser scanning microscope.
Excitation and detection of the samples were carried out in
sequential mode to avoid overlapping of signals. Sections were
scanned with laser intensity, confocal aperture, gain and black-
level setting kept constant for all samples. Optical sections were
obtained at increments of 0.3 mm in the z-axis and were digitized
with a scanning mode format of 512 x 512 or 1024 x 1024 pixels
and 256 grey levels. The confocal serial sections were processed
with the Leica LCS software to obtain three-dimensional
projections. Image rendering was performed by adobe Photoshop
software. The original green fluorescent confocal images were
converted to grey-scale and median filtering was performed. An
intensity value ranging from 0 (black) to 255 (white) was assigned
to each pixel.
Background fluorescence was subtracted and immunofluores-
cence intensity (IF) was calculated as the average for each selected
area. The fluorescence intensity at the selected areas, linearly
correlated with the number of pixels, was quantitatively analysed
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using the standard imaging analysis software of an NIS-Elements
system. To each sample was assigned a code number and the
score, referred to as ImmunoFluorescence Intensity Score (IFIS),
was determined by an observer who was blind to tissue groups
during analysis [31,32].
RNA Isolation and Quantitative Real Time-PCR
One sample formalin fixed and paraffin embedded for each
patient was used for histological evaluation and mRNA extraction
and quantification. Total RNA was isolated from formalin-fixed,
paraffin-embedded samples (the last 20 samples of NM, 10 MA,
and 20 CRC). Total RNA was extracted from 10 mm sections,
using High Pure RNA Paraffin Kit (Roche Diagnostics S.p.A.,
Milan, Italy) according to the manufacturer’s instructions; this was
followed by DNase treatment and removal of contaminating DNA
from the RNA. RNA content was determined by spectrophotom-
etry and first-strand cDNA was synthesized from 2 mg of total
RNA with Superscript VILO cDNA synthesis kit (Invitrogen S.r.l.,
Milan, Italy) according to the manufacturer’s instructions.
Real-time PCR was done on the iCycler iQReal-Time De-
tection System (Bio-Rad) using Go-taq qPCR Master Mix
(Promega, Milan, Italy) according to detailed manufacturer’s
protocols. The iQReal-Time Detection System software generated
a standard curve from 10-fold serial cDNA dilutions, and the
threshold cycle was normalized for each standard curve. To
confirm amplification of a specific product, melting curve analysis
was performed and PCR products were directly visualized on 2%
low-melting agarose gels. The copy numbers for all samples were
normalized with the data obtained from GAPDH, which was used
as a control. Data were expressed as fold induction in pathological
tissue referred to normal mucosa (DCt Method Using a Reference
Gene or Livak Method) [33].
Specific primers for zbtb7b were designed using Primer3
software (Perkin-Elmer Applied Biosystems). Total gene specificity
of the nucleotide sequence chose for primer was confirmed by
results of BLAST searches (GenBank database sequences). Specific
primer pairs were as follows: zbtb7b, forward 59-tgagaggagaa-
gatggggag-39 and reverse 59-cggatggtgaggtcacatag-39; GAPDH,
forward 59-agccacatcgctcagacac-39 and reverse 59-gcccaatacgac-
caaatcc-39. The cycling conditions were established as follows:
single cycle at 95uC for 2 minutes, 40 cycles at 95uC for 15
seconds, and at 60uC for 60 seconds.
Colocalization Analysis
To examine the cellular localization of ThPOK within CD4+,
CD8+, CD56+ cells, multiple immunofluorescence staining of
rabbit anti-zbtb7b antibody(Sigma) with mouse anti-CD4, mouse
anti-CD8, mouse anti-CD56 (Dako), goat anti-Foxp3, goat anti-
RUNX3 or anti granzyme B (anti-GZMB) (Santa Cruz), were
applied according to our previous published method [31,32].
The samples, processed for multiple fluorescence (DAPI, FITC,
Cy3 and CFTM647), were sequentially excited with the 405 nm/
25 mW lines of a blue diode laser, the 488-nm/20 mW lines of the
Argon laser, the 543 nm/1.2 mW lines of a HeNe laser and the
633 nm/102 mW lines of a HeNe laser.
Optical sections were obtained at increments of 0.3 mm in the z-
axis and were digitized with a scanning mode format of 512 x 512
or 1024 x 1024 pixels and 256 grey levels. For colocalization
analyses, the different channel images were acquired indepen-
dently, and photomultiplier gain for each channel was adjusted to
minimize background noise and saturated pixels. Once acquired,
images were not modified further.
The degree of colocalization between red (Cy3) and green signal
(FITC) was calculated based on the integrated density of each
signal independently for each different sections. Manders co-
efficient was calculated with ImageJ using the JACoP tool [34].
Manders coefficient varies from 0 to 1, corresponding to non-
overlapping images and 100% colocalisation between the two
images, respectively. The intensity of fluorescence for each marker
was multiplied for the corresponding Manders coefficient, in order
to obtain the normalized colocalization levels.
To evaluate triple colocalization of FITC, Cy3 and CFTM64,
data were analyzed with ImageJ by selecting single slices and the
co-localization of three different molecules was evaluated by the
presence, intensity and distribution of the color resulting from the
overlapping of RUNX3, CD8 and ThPOK, and the color
resulting from the overlapping of RUNX3 and CD8 [35]. In
cases where we had three fluorochromes, the triple colocalization
was regarded as being separate and not contributing to the double.
Statistical Analysis
All quantitative data for NM, MA, and CRC are reported as
mean 6 SE. The difference in average expression in the different
groups of colorectal lesions, was tested for statistical significance
using Kruskal-Wallis analysis, followed by Student-Newman-Keuls
tests. The value of P,0.05 was chosen to indicate a significant
difference.
Results
Western Blot Analyses of CD4, CD8, and CD56
In order to investigate the expression profile of lymphocyte
subpopulations involved in colorectal carcinogenesis and affected
by ThPOK, we evaluated a panel of antibodies specific for
proteins which identify CD4+, CD8+ and CD56+ lymphocytes.
Lysates of NM, MA, and CRC were analyzed by Western blotting
followed by densitometric analysis of the immunoreactive bands.
Western blotting in analyzing the protein profile of CD4 showed
one specific immunoreactive band at 58 kD. CD4 protein levels in
MA were not significantly increased with respect to NM (Figure 1,
panel A; densitometric ratio 1.0360.07), whereas decreased levels
were observed in CRC. (Figure 1, panel A; densitometric ratio of
0.6560.05, p,0.05 vs NM). Western blotting data showed that
the levels of CD8 protein had a significant upward increase from
NM to CRC, with a slightly detectable band in NM; densitometric
ratios were 1.6660.20 for MA and 2.1960.15 for CRC. (Figure 1,
panel B; band at 32 kD). The CD56 protein levels, corresponding
to a 140-kD band, decreased fivefold during colorectal cancer
progression (Figure 1, panel C; densitometric ratios of 0.4560.11
in MA and 0.2060.05 in CRC versus NM).
Quantification of ThPOK Protein and mRNA
The amounts of ThPOK protein and mRNA were quantified
using Western blot and qRT-PCR analyses. Western blotting
showed that the expression of ThPOK protein was markedly
enhanced during colorectal carcinogenesis. ThPOK protein levels
were increased 4.360.77-folds in MA and 3.7860.27-fold in CRC
compared to NM (Figure 2, panel A). The amount of ThPOK
mRNA confirmed an upregulation since the early neoplastic
lesions, with a fold change of 3.3360.79 in MA and 3.1661.13 in
CRC vs NM (Figure 2, panel B).
Fluorescence Analysis of CD4+, CD8+, CD56+, and
ThPOK+ cell Infiltration
In order to evaluate differences between NM, MA and CRC in
a quantitative mode, we performed immunofluorescence experi-
ments by confocal microscopy which allows not only to obtain
a good resolution of subcellular structures in very thick samples but
ThPOK in Colorectal Carcinogenesis
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also to perform the quantification of the proteins detected. The
confocal analysis confirmed the data obtained by Western blot
analysis.
The fluorescence level of CD4 immunostaining was similar in
NM and in MA. Furthermore, there was a significant decrease of
CD4 immunostaining in CRC compared to NM and MA (Table 1
and Figure 3, panels A-C).
Confocal analysis of CD8+ cells showed that the mean IFIS
increased steadily from NM to MA and CRC (Table 1, P,0.05
between all pairs of groups, and Figure 3, panels D-F,).
The expression of CD56 was very high in all samples of NM,
decreasing substantially in MA, and showing the lowest level of
expression in CRC; in fact, very few stained cells were present in
most samples of CRC (Table 1, P,0.05 between all pairs of
groups, and Figure 3, panels G-I).
The samples of NM were weakly stained for ThPOK, whereas
both in MA and in CRC ThPOK staining was significantly higher
(Table 1, P,0.05 vs NM, and Figure 3 panels A-I).
Colocalization Analyses
In order to identify the type of stromal cells positive for CD4,
CD8 and CD56 which mostly expressed ThPOK, we performed
cellular colocalization studies by double immunofluorescence
analysis coupled with confocal microscopy. Figure 4 shows the
localization of anti-CD4, anti-CD8 and anti-CD56 antibodies
coupled with ThPOK staining in samples of NM, MA, and CRC.
The colocalization image was used to calculate the overlap
coefficient according to Manders [32]. We observed interesting
changes in the colocalization levels during neoplastic progression
(Figure 4).
The degree of ThPOK/CD4 colocalization in NM and MA
was similar, it was significantly lower in colorectal carcinomas
(Figure 4, panel A). The Manders coefficient for ThPOK and CD8
showed a peak in MA samples. Although the increased alignment
of ThPOK and CD8 was more prominent in MA compared to
colorectal carcinomas, in both groups it was statistically higher
than in NM (P,0.05 between all pair of groups, Figure 4, panel
B). The colocalization degree of ThPOK with CD56 increased in
samples of colorectal carcinomas compared to normal mucosa and
microadenomas (P,0.05 Figure 4, panel C), although the level of
CD56 in carcinomas was very low.
By normalizing the co-expression data to the fluorescence levels,
we observed that, in NM, most of ThPOK+ cells was CD4+, and
a lower level of colocalization was observed between ThPOK and
the others markers. In MA the level of colocalization of ThPOK
with CD4 remained similar to NM, whereas the highest
colocalization was with CD8, statistically higher when compared
to NM (P,0.05 vs NM), and smaller colocalization with CD56
Figure 1. Quantification of lymphocytes subpopulations markers. Western blot analysis of normal colorectal mucosa (NM), microadenomas
(MA), and colorectal cancer (CRC), using anti-CD4, anti-CD8, anti-CD56 antibodies. Mean densitometric data of protein expression were analyzed
using a NIH Image J software. Band intensities for NM were arbitrarily set to 1. *P,0,05 vs NM; { P,0,05 vs CRC. Panel A: CD4 densitometric analysis,
and specific bands at 58 kD for CD4 and at 42 kD for a-actin. Panel B: CD8 densitometric analysis and bands at 32 kD for CD8 and 42 kD for a-actin.
Panel C: CD56 densitometric analysis, and bands at 140 kD for CD56 and at 42 kD for a-actin.
doi:10.1371/journal.pone.0054488.g001
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(P,0.05 vs NM). In CRC there was a lower level of colocalization
with CD4 (P,0.05 vs both NM and MA), the increased levels of
double staining of ThPOK and CD8 was similar to MA, and the
amount of ThPOK+/CD56+ cells was almost undetectable
(Figure 4, panel D).
ThPOK and Treg Lymphocytes
We performed cellular colocalization studies by triple immu-
nofluorescence analysis coupled with confocal microscopy in order
to look for a coexpression of ThPOK and Foxp3 in colorectal
carcinogenesis. ThPOK did not colocalize with Foxp3 in all the
specimens, but either shown a comparable expression profile. The
IFIS levels of Foxp3 increased from NM (IFIS 23.563.2) to MA
(IFIS 40.766.7) and CRC (IFIS 49.463.4) (Figure 5, panel A).
ThPOK and CD8+ Effector Functions
We subsequently analyzed the presence of effector markers, as
GZMB or RUNX3, in CD8+ cells regarding to the ThPOK
presence, by performing triple immunofluorescence staining.
The coexpression of ThPOK and GZMB in CD8+ cells wass
almost undetectable; ThPOK did not colocalize with GZMB,
neither in NM, MA or CRC. The amount of GZMB decreased
from NM (IFIS 59.669.1) to CRC (IFIS 26.663.7), in contrast to
the increase of ThPOK since microadenomas (Figure 5, panel B).
Also the levels of RUNX3 fluorescence decreased from NM
(IFIS 59.669.6) to MA (IFIS 45.366.9) and to CRC (IFIS
20.8612.2) (Figure 5, panel C).
In all the samples the levels of RUNX3-ThPOK-coexpressing
CD8+ T cells were lower with respect to the levels of RUNX3 -
positive CD8+ T cells. This was more evident in MA, where there
was a maximum level of RUNX3-positive CD8+ T cells. This
difference was not significant in CRC samples, where the level of
RUNX3-ThPOK-coexpressing CD8+ T cells and of RUNX3-
positive CD8+ T cells became equal (Figure 5, panel D and
Figure 6).
Discussion
Our study focused on colorectal carcinogenesis, and expecially
on the very early stages of colorectal cancer progression, identified
by dysplastic aberrant crypt foci, also referred to as microadeno-
mas [30,36]. In this context we tried to define a possible regulator
of the transformations making the immune system unable to
control the development of colorectal cancer at the very early
stages of onset.
We analyzed helper T lymphocytes, cytotoxic T lymphocytes,
and natural killer T cells, identified respectively by CD4, CD8 and
CD56 markers in human normal colorectal mucosa, microade-
nomas and carcinomas, using immunofluorescence techniques and
protein quantification analyses by Western blot. In microadeno-
mas no significant change in CD4+ cells was observed with respect
to normal mucosa. On the other hand, a significant decrease of
these cells in carcinomas was observed. Moreover, we noted
a gradual increase of CD8+ T cells, during tumour progression.
Finally a strong decrease of CD56+ cells in microadenomas was
apparent, and this decrease was even more pronounced in
carcinomas, where CD56+ cells were almost undetectable.
We then analyzed ThPOK, a protein with a prominent role in
the commitment of some leucocytic lineages, such as helper,
cytotoxic and natural killer T cells, which have a pivotal role in
defining the aggressiveness and prognosis of various types of
cancer, including colorectal carcinomas [4,5]. ThPOK was
observed to have an unexpected increase in preneoplastic
Figure 2. ThPOK protein and mRNA during colorectal neoplastic progression. Measurement of ThPOK protein and mRNA in normal
colorectal mucosa (NM), microadenomas (MA), and colorectal cancer (CRC). Panel A: NM, MA and CRC were subjected to SDS–PAGE/western blot
using the anti-ThPOK antibody; densitometric analysis and bands at 60 kD for ThPOK and at 42 kD for a-actin.* P,0.05 vs NM. Panel B: Real-time
PCR analysis of ThPOK mRNA in NM, MA and CRC. *P,0,05 vs NM. Band intensity of ThPOK protein and ThPOK mRNA level for NM were arbitrarily set
to 1.
doi:10.1371/journal.pone.0054488.g002
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Figure 3. Confocal immunofluorescence staining. Examples of confocal analysis of cryosections of normal colorectal mucosa (NM),
microadenoma (MA), and colorectal carcinoma (CRC), labelled by DAPI (blue), ThPOK (red), CD4 (green), CD8 (green), and CD56 (green). Double
immunolabelled cells appear as yellow spots. Panels A-C: Colocalization imaging of ThPOK with CD4 in NM (panel A), MA (panel B) and CRC (panel
C). Panels D-F: Double immunolabelling performed by ThPOK and CD8 in NM (panel D), MA (panel E) and CRC (panel F). Panels G-I:
Immunostaining with ThPOK and CD56 in NM (panel G), MA (panel H) and CRC (panel I). Scale bar = 80 mm.
doi:10.1371/journal.pone.0054488.g003
Table 1. Immunofluorescence quantification by confocal analysis.
CD4 IFIS (mean 6 SEM) CD8 IFIS (mean 6 SEM) CD56 IFIS (mean 6 SEM) ThPOK IFIS (mean 6 SEM)
NM 26.6163.26 17.2262.64 63.94611.98 24.963.0
MA 27.2162.31 30.7463.56* 24.3265.18* 44.6965.64*
CRC 13.3562.59* 46.2566.42* 8.0663.31* 45.4165.02*
Fluorescence quantification (ImmunoFluorescence Intensity Score, IFIS, see Materials and Methods) of CD4, CD8, CD56 and ThPOK in normal colorectal mucosa (NM),
microadenoma (MA) and colorectal carcinoma (CRC). * p,0.05 vs normal colorectal mucosa.
doi:10.1371/journal.pone.0054488.t001
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PLOS ONE | www.plosone.org 6 January 2013 | Volume 8 | Issue 1 | e54488
colorectal lesions, suggesting its involvement since the earliest
phases of immune system remodelling in the colorectal neoplastic
microenvironment.
By morphological analysis with immunofluorescence coupled
with confocal microscopy, we observed changes in the immuno-
logical pattern during neoplastic progression. In normal mucosa
there was a predominance of CD56+ cells, and a lower infiltration
of T lymphocytes (both helper and cytotoxic), associated with
lower levels of ThPOK. In microadenomas, we observed both
a decrease of CD56+ cells and an increase of CD8+ T cells,
paralleled by a relevant increase of ThPOK immunostaining.
Finally, in carcinomas, the presence of CD56+ cells was scarce,
with a prevalence of CD8+ T cells together with an increase of
ThPOK labeling.
Many studies have analyzed the presence/amount of helper and
cytotoxic T cells in colorectal carcinomas, but only few evaluated
changes during colorectal cancer development, since normal
mucosa and microadenomas. In addition, data on quantification
of lymphocyte populations in colorectal carcinogenesis are
currently elusive.
It has been demonstrated that the increased expression of genes
specific for cytotoxic T lymphocytes, as CD8a, granzyme B, or
perforin was related to the absence of early metastatic invasion of
colorectal cancer, and it could also improve patient survival
[37,38].
At the moment, data are not available regarding a tumour-
specific activation of CD8+ T cells, but it has been demonstrated
a tumour-induced inhibition of CD8+ T cells, related to tumour
stage. There are at least three mechanisms to account for
a disfunction of CD8+ cells: i) cytotoxic T lymphocytes may be
inactive, as revealed by the low levels of cytotoxic markers, ii)
cytotoxic T lymphocytes may be apoptotic, iii) cytotoxic T
lymphocytes may be immature [39–44].
ThPOK was initially considered a regulator of CD4+ lineage.
Further experiments have shown its activation not only in CD4+
lymphocytes, but also in peripheral CD8+ cells [45]. These data
are consistent with the hypothesis that ThPOK is important in
maintaining the CD4+ phenotype in physiological conditions, as in
normal mucosa this protein is mostly expressed in CD4+ cells.
Foxp3 is a master regulator of a class of immunosuppressive T
cell, that has a central role in cancer progression. Our studies
failed to find a correlation between foxp3 and ThPOK, but as
reported by others works [46,47], an increase of foxp3+ cells
during colorectal cancer progression was evident.
However, the novelty as well as the main finding of the present
work is the observation that ThPOK becomes prevalent in CD8+
Figure 4. Colocalization analysis. Quantitative analysis of co-expression levels by Manders coefficient in normal mucosa (NM), microadenomas
(MA), and colorectal cancer (CRC), analyzing the ratio between ThPOK/CD4 (panel A), ThPOK/CD8 (panel B), and ThPOK/CD56 (panelC). *P,0,05 vs
NM; { P,0,05 vs CRC. Panel D: Normalized co-expression levels in normal mucosa (NM), microadenomas (MA), and colorectal cancer (CRC), between
ThPOK and CD4 (white bars), ThPOK and CD8 (black bars), and ThPOK and CD56 (gray bars). *P,0,05 vs CD4; { P,0,05 vs CD56.
doi:10.1371/journal.pone.0054488.g004
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T cells during the earliest dysplastic phases of colorectal cancer
development. This fact outlines a new perspective on the
hypothesis of the effectiveness of CD8+ T cells against colorectal
cancer cells, suggesting a possible mechanism of the reduced
immune response to colorectal tumours.
Up to now, no study has investigated the role of ThPOK, or
other protein regulators of immune plasticity, in peripheral organs
during progression of solid tumours. ThPOK is required both for
CD4+ cells commitment and for helper identity maintenance.
ThPOK, when introduced into mature CD8+ T cells, prevents the
inappropriate expression of CD8-lineage genes, including CD8,
perforin and granzyme B, and the transcription factors Runx3 and
Eomes [28]. Thus, ThPOK could represent a new mechanism
explaining the low effector property of CD8+ T cells against
tumour cells, just mediated by ThPOK. Since ThPOK controls
and decreases various cytotoxic effectors, it could be responsible
for the inactivation of CD8+ T cells and, thus, it could be actively
involved in contributing to the ‘‘immune escape’’ phenomenon.
This can be supported also by our results that indicate a decrease
of GZMB expression during colorectal neoplastic progression in
parallel with an increase level of ThPOK amount. Furthermore,
ThPOK expression in CD8+ cell seems to exclude GZMB
expression, in NM as well as in MA and CRC.
RUNX3 levels decreased during colorectal carcinogenesis, too,
as already reported by others studies [48]. By colocalization
analysis we observed that CD8+ cells expressing RUNX3
decreased in carcinomas, while the presence of ThPOK increase
in the same cells. This may suggest a role of ThPOK in the
modification of CD8+ cells activity against cancer cells. Functional
studies are necessary to clarify a cause-effect mechanism for this
observation.
These observations, considered together, seems to suggest
putative roles of ThPOK not only in maintaining the phenotype
of helper T lymphocytes, as already demonstrated by other studies
[29], but also in controlling the inactivation of CD8+ T cells.
Many works, even recently, have analyzed the presence of
cytotoxic or helper T cells in the tumour microenvironment of
colorectal cancer [49]. NK and NKT cells have a key role in
normal homeostasis and tissue differentiation of the gut [17,18];
in vitro, they act quite well as effector cells against tumour target
cells [50]. The role of NK and NKT cells infiltration in colorectal
cancer is not well understood [19], and few studies have analyzed
CD56+ cells in colorectal cancer progression: they reported low
levels of CD56+ cells in colorectal cancer [22,23], and the
evidence that infiltration of NK cells in malignant tumours was
associated with a favourable outcome [21]. The decrease in
number of CD56+ cells during neoplastic progression foreshadows
a major role for natural killer cells in controlling tumour
progression.
ThPOK is considered, among other roles, a regulator of the
functions of natural killer T cells [51]. Our study shows its lack of
influence on natural killer and natural killer T cells, identified by
the CD56 marker, during colorectal cancer progression. We did
not find a consistent presence of ThPOK-CD56 colocalization in
Figure 5. Foxp3, GZMB and RUNX3 fluorescence levels. Fluorescence levels of Foxp3 (panel A), GZMB (panel B), RUNX3 (panel C)
immunostaining. *P,0,05 vs NM; { P,0,05 vs CRC. RUNX3 level in CD8+ T cells coexpressing (white bars) and not coexpressing (black bars) ThPOK in
NM, MA and CRC (panel D). *P,0,05.
doi:10.1371/journal.pone.0054488.g005
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normal mucosa, and the number of CD56+ cells became almost
undetectable during neoplastic progression. However, the marked
decrease of CD56+ cells, together with the action exerted by
ThPOK in CD8+ T lymphocytes, may be the key mechanisms of
tumour microenvironment modification, referred as immunoedit-
ing, which makes the immune system inefficient against neoplastic
growth.
The number of blood white cells which have been typed is
currently growing. Recent studies performed by flow cytometry
showed a great plasticity of the immune system in terms of patterns
or networks assumed by various leucocytic lineages. The results of
the present study suggest that a pattern of proteins might exist
which could define an overall status of the immune system, not
a subpopulation of leukocytes in particular. In other words,
colorectal cancer development could somehow influence not only
the type of infiltrating cells themselves, but also drive its plasticity.
ThPOK may be considered one of the main regulators of such
plasticity, influencing the immune escape mechanisms since the
early onset of neoplastic clones.
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